Journal
NATURE
Volume 463, Issue 7280, Pages 507-U123Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nature08720
Keywords
-
Categories
Funding
- NIH
- National Institute of General Medical Sciences [GMO41883]
- Charles King Trust
- National Heart, Lung, and Blood Institute (NIH) [K99, 1K99HL097083]
Ask authors/readers for more resources
Vitamin K epoxide reductase (VKOR) generates vitamin K hydroquinone to sustain c-carboxylation of many blood coagulation factors. Here, we report the 3.6 angstrom crystal structure of a bacterial homologue of VKOR from Synechococcus sp. The structure shows VKOR in complex with its naturally fused redox partner, a thioredoxin-like domain, and corresponds to an arrested state of electron transfer. The catalytic core of VKOR is a four transmembrane helix bundle that surrounds a quinone, connected through an additional transmembrane segment with the periplasmic thioredoxin-like domain. We propose a pathway for how VKOR uses electrons from cysteines of newly synthesized proteins to reduce a quinone, a mechanism confirmed by in vitro reconstitution of vitamin K-dependent disulphide bridge formation. Our results have implications for the mechanism of the mammalian VKOR and explain how mutations can cause resistance to the VKOR inhibitor warfarin, the most commonly used oral anticoagulant.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available